LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES
Adverse reaction reported in 15,000 FDA reports across 12 drugs.
15,000
Total Reports
12
Drugs Involved
Mepolizumab
Most Reported Drug
Drugs Associated with LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES
Drugs where "LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Mepolizumab | 4,206 | |
| 2 | Tiotropium Bromide | 3,262 | |
| 3 | Ciclesonide | 1,772 | |
| 4 | Budesonide | 1,477 | |
| 5 | Fluticasone Furoate / Vilanterol Trifenatate | 1,371 | |
| 6 | Abaloparatide | 855 | |
| 7 | Mometasone | 564 | |
| 8 | Atazanavir | 376 | |
| 9 | Raltegravir | 352 | |
| 10 | Lopinavir / Ritonavir | 347 | |
| 11 | Efavirenz | 216 | |
| 12 | Umeclidinium | 202 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused loss of personal independence in daily activities. Always consult your healthcare provider.